Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
New dementia adviser says thousands should be given access to experimental drugs

In an interview with The Telegraph, the World Dementia Envoy said any promising drugs should be given to “large populations” in order to speed the search for a breakthrough - as happened decades ago in the battle against HIV.

Published
24 March 2014
From
Daily Telegraph
More Life Years Lost Through Smoking Than HIV in 18,000-Person Analysis

Antiretroviral-treated HIV-positive people lost more life years compared with the general population because of smoking than because of HIV infection, according to analysis of nearly 18,000 HIV-positive people in the ART Cohort Collaboration (ART-CC). The impact of smoking on mortality rose steeply with age.

Published
24 March 2014
From
NATAP
Gilead offers Egypt new hepatitis C drug at 99 percent discount

Gilead Sciences, facing mounting criticism over the high price of its new hepatitis C pill Sovaldi, has offered to supply the medicine to Egypt at a 99 percent discount to the U.S. price. While the drug will still cost $900 for a 12-week course of treatment, that is a fraction of the $84,000 charged for a course of treatment in the United States.

Published
24 March 2014
From
Reuters
US Lawmakers Attack Cost of New Hepatitis Drug

A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday.

Published
24 March 2014
From
New York Times
Ed Miliband: Coalition must take responsibility for lack of HIV testing by GPs

The Labour leader told PinkNews.co.uk in an exclusive interview that he was alarmed by reports of healthcare professionals failing to offer HIV tests to groups most at risk of carrying the virus. “The Government has a responsibility to work with GPs and health centres to make sure, not only are they aware of their responsibilities, but also to encourage them to provide testing” he said.

Published
20 March 2014
From
Pink News
NY deal with drug maker paves way for plan to end HIV

State agreement with pharmaceutical firm is part of plan to reduce incidence of AIDS.

Published
20 March 2014
From
Albany Times Union
Merck HIV Drug Strategy Seen Shielding Patent: Corporate India

Merck & Co. (MRK) is set to sell an HIV medication in India by mid-year in partnership with local company Cipla Ltd. (CIPLA), a strategy that may help the U.S. drugmaker protect its patent as the Asian nation seeks cheaper generics.

Published
20 March 2014
From
Bloomberg
Treatment as prevention: The value of early treatment of HIV infection

The authors of a new paper in Health Affairs concluded that the strategy of early cART prevented 188,000 new HIV cases during 1996-2009, and the value of the survival gains was more than double the increase in drug manufacturers’ revenues from early cART initiation.

Published
19 March 2014
From
The Incidental Economist
Trouble Ahead for Gilead and Sovaldi?

Atop ever-inflating sales estimates for Gilead Science's blockbuster Sovaldi, patent battles also continue to crop up. Late last week Idenix Pharmaceuticals added three more suits to the pile, filing in France, Germany and the UK for patent infringement on nucleosides, a precursor to the compound in Sovaldi. This is in addition to two lawsuits it has pending against Gilead stateside since late last year.

Published
19 March 2014
From
Motley Fool
Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016

Published
19 March 2014
From
European Commission

Filter by country